REAX’s stock is tanking—down 50% this year, trading near $1.70—raising alarms about its viability. Despite slight EPS improvements, the company’s still losing money, struggling with high costs, and generating weak free cash flow. Analysts see little upside and recommend shifting focus to a more stable, cash-flowing industrial play riding a strong upgrade cycle.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
